Sanofi Research And Development Expense

• Sanofi showed an increase of +6.1% in Research And Development Expense from 2024 to 2025.
• This data is from Sanofi's annual report (Form 10-K), filed with the SEC on February 17, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), Sanofi's Research And Development Expense has grown by 51.6%.
• Historical annual values: Fiscal year 2025: $7.84 billion | Fiscal year 2024: $7.39 billion | Fiscal year 2023: $6.51 billion | Fiscal year 2022: $6.50 billion | Fiscal year 2021: $5.69 billion | Fiscal year 2020: $5.53 billion | Fiscal year 2019: $6.02 billion | Fiscal year 2018: $5.89 billion | Fiscal year 2017: $5.47 billion | Fiscal year 2016: $5.17 billion.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026